Jill Collins

Jill Collins, PhD has a diverse work experience spanning various roles and industries. Jill is currently an Official Member of Forbes Agency Council. Prior to that, they served as the CEO + Chief Strategy Officer at Audacity Health since December 2017. From June 2016 to December 2017, Jill worked as the Vice President of Genomics Strategy at GenomeDx Biosciences Inc. Jill also held the role of Vice President of Medical Strategy at Audacity | a huntsworth health agency from December 2013 to June 2016. Before this, Jill worked as the Director of Marketing at Prognosys Biosciences from May 2011 to December 2012 and as the Associate Director of Business Development at GenWay Biotech from July 2008 to May 2011. Jill started their career as a Postdoctoral fellow at Sanford-Burnham Medical Research Institute from October 2006 to July 2008. Jill obtained their PhD while serving as a Graduate Student at the University of Illinois at Chicago from 2001 to 2006.

Jill Collins, PhD obtained their Ph.D. in Medicinal Chemistry from the University of Illinois Chicago, where they studied from 2001 to 2006. Prior to that, they earned their Bachelor of Science degree in Chemistry from the University of Dayton, completing their studies from 1997 to 2001.